Osteoarthritis remains one of the leading causes of pain and disability worldwide. Experts say people with osteoporosis ...

A blockbuster Amgen drug for osteoporosis now carries the FDA’s strictest warning that its use can lead to dangerously low levels of calcium in the blood. This complication, hypocalcemia, is a ...

A $7 million study beginning this summer at Wake Forest University and Wake Forest University School of Medicine will help determine whether a combination of resistance training plus ...

Figure 1 shows annual osteoporosis prevalence and treatment estimates from MEPS years 1999 to 2005 among the sample of patients ages 50 years and older who self-reported osteoporosis. Self-report of ...

LOS ANGELES - With the launch of the first prescription osteoporosis medication 15 years ago, millions of Americans with the bone-thinning disease began taking the drugs and never looked back. But now ...

Prevention of osteoporosis should be considered before a bone break occurs, and many patients at risk for the chronic bone condition may benefit from pharmacologic options. "Most current guidelines ...

A research team from the Department of Pharmacology and Pharmacy, LKS Faculty of Medicine of the University of Hong Kong (HKUMed), has found that nitrogen-containing bisphosphonates (NBPs), a ...

Please provide your email address to receive an email when new articles are posted on . “There is abundant evidence that men are not adequately screened for osteoporosis, and those with osteoporosis ...

Researchers at the University of São Paulo (USP) in Brazil have discovered that two osteoporosis drugs (etidronate and tiludronate) may combat diseases caused by iron accumulation in the body. In ...

On Monday, the Food and Drug Administration issued a new draft guidance that requires drug manufacturers to conduct long-term nonclinical bone quality studies for osteoporosis treatments. The agency ...

Researchers at the University of São Paulo (USP) in Brazil have discovered that two osteoporosis drugs (etidronate and tiludronate) may combat diseases caused by iron accumulation in the body. In ...

Purpose. Trends in the use of different treatments for osteoporosis among the civilian, ambulatory U.S. population are described. Methods. Data from the Medical Expenditure Panel Survey (MEPS) were ...